CIMT Cancer Cell Therapy Summit hosted by Champalimaud

Join us at the Champalimaud Foundation in Lisbon for transformative discussions and collaboration on cellular cancer immunotherapies. Explore promising paths towards effective cellular treatment modalities for patients with solid cancer and the boundaries of synthetically engineered immune cells.

Key discussion points of this Summit will include: · Promising cellular treatment modalities for solid cancers · Boundaries and potential of synthetically engineered immune cells · The innovation gap between academic and biotech/pharma-driven research · Challenges of conducting safe, biologically, and clinically relevant phase I/II clinical trials

We're honored to have an exceptional lineup of confirmed speakers:

  • Mark Yarmarkovich (New York University)

  • Sebastian Klobuch (Netherlands Cancer Institute)

  • Davide Bedognetti (Kite Pharma)

  • Sebastian Kobold (University Hospital of Munich)

  • Mirjam Heemskerk (Leiden University Medical Center)

  • Stanley Qi (Stanford University)

  • Tal Danino (Columbia University)

  • Andreas Mackensen (University Hospital Erlangen)

  • Judith Kroep (Leiden University Medical Center)

  • Christian Blank (Netherlands Cancer Institute)

  • Jason Bock (CTMC Houston)

  • Marie Henriksson (Karolinska Institute)

  • Cécile Alanio (Curie Institute)

For more information, please see www.cimt.eu/cancer-cell-therapy-summit

Christine Castle